JCO Precision Oncology : Impact Factor & More
eISSN: 2473-4284pISSN: 2473-4284
Share this on:
Key Metrics
CiteScore 
6.6
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.98
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JCO Precision Oncology
JCO Precision Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JCO Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JCO Precision Oncology
Identification of Predictive Biomarkers for Chemoradiotherapy Response in Rectal Cancer.
- 1 Aug 2026
- JCO precision oncology
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay.
- 1 Aug 2026
- JCO precision oncology
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.
- 1 Aug 2026
- JCO precision oncology
Using Disease-Agnostic Genomic Liquid Biopsy in Complex Diagnoses: Real-Life Example of cfChIP-Seq in a Fever of Unknown Origin.
- 1 Aug 2026
- JCO precision oncology
Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring
- 23 Jul 2026
- JCO Precision Oncology
Prognostic Significance of Cell-Free DNA Derived 5-Hydroxymethylcytosine Signatures in Newly Diagnosed Multiple Myeloma
- 23 Jul 2026
- JCO Precision Oncology
Identification of Predictive Biomarkers for Chemoradiotherapy Response in Rectal Cancer.
- 1 Aug 2026
- JCO precision oncology
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay.
- 1 Aug 2026
- JCO precision oncology
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.
- 1 Aug 2026
- JCO precision oncology
Using Disease-Agnostic Genomic Liquid Biopsy in Complex Diagnoses: Real-Life Example of cfChIP-Seq in a Fever of Unknown Origin.
- 1 Aug 2026
- JCO precision oncology
Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring
- 23 Jul 2026
- JCO Precision Oncology
Prognostic Significance of Cell-Free DNA Derived 5-Hydroxymethylcytosine Signatures in Newly Diagnosed Multiple Myeloma
- 23 Jul 2026
- JCO Precision Oncology
FAQs on JCO Precision Oncology
How long has JCO Precision Oncology been actively publishing? 
What is the publishing frequency of JCO Precision Oncology?
How many articles did JCO Precision Oncology publish last year?
What is the eISSN & pISSN for JCO Precision Oncology?
What is Citescore for JCO Precision Oncology?
What is SNIP score for JCO Precision Oncology?
What is the SJR for JCO Precision Oncology?
Who is the publisher of JCO Precision Oncology?
